Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$67.67
-1.52%
Mkt Cap $5.91B
Analyst Ratings
No recent rating data.
Price Target (23 analysts)
$74.83
Range $60.00 – $109.00
Implied Upside
+10.6%
Consensus $74.83 vs current $67.67